Trump’s Crackdown on Federal Regulations

The President has signed an executive order requiring that federal agencies, including the FDA, to cut two regulations for every new one they adopt.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, STAFF OF POTUSPresident Donald Trump signed an executive order on Monday (January 30) that will require federal agencies to repeal two existing regulations for every new one they adopt. “It is the policy of the executive branch to be prudent and financially responsible in the expenditure of funds,” according to the executive order. “It is essential to manage the costs associated with the governmental imposition of private expenditures required to comply with Federal regulations.”

As he signed the order, STAT News reported, Trump said he was fulfilling a campaign promise to loosen government regulations and promote innovation. “There will be regulation, there will be control,” he said. “But it will be normalized control.”

Rick Pollack, CEO of the American Hospital Association, praised the executive order in a statement. “Reducing the administrative complexity of health care would allow providers to spend more time on patients, not paperwork,” he wrote. “Excessive red tape not only stands as a barrier to care but as a key driver of cost.”

But some officials were less certain that the executive order was a good idea. As STAT reported, the order could cripple the 21st Century Cures Act, the landmark legislation passed to accelerate US ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Alzheimer: Phosphorylation of Tau proteins leads to disintegration of microtubuli in a neuron axon stock photo

Advancing Alzheimer’s Disease Detection with Brain-Derived pTau217 Assays

Alamar Biosciences logo
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Human iPSC-derived Models for Brain Disease Research

Human iPSC-derived Models for Neurodegenerative Disease Research

Fujifilm

Products

Beckman Logo

Beckman Coulter Life Sciences Introduces the Biomek i3 Benchtop Liquid Handler, a Small but Mighty Addition to its Portfolio of Automated Workstations

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging